500
0
0
Skip to Content
Lung Cancer Europe News
Home
News
Policy
Organisation news
Events
Access
Prevention & risk
11th Report
11th Report Press Release
10th Report
English
Lung Cancer Europe News
Home
News
Policy
Organisation news
Events
Access
Prevention & risk
11th Report
11th Report Press Release
10th Report
English
Home
Folder: Categories
Back
News
Policy
Organisation news
Events
Access
Prevention & risk
Folder: Annual Reports
Back
11th Report
11th Report Press Release
10th Report
English
Back
Why People with Lung Cancer Face a Higher Risk of Hospital Infections
Prevention & risk, Policy, Treatment, Advocacy, LuCE News, News Web Team 06/05/2026 Prevention & risk, Policy, Treatment, Advocacy, LuCE News, News Web Team 06/05/2026

Why People with Lung Cancer Face a Higher Risk of Hospital Infections

Read More
What is subcutaneous pembrolizumab and what does the NHS rollout mean for people living with lung cancer in Europe?
Access, Treatment, LuCE News, News Web Team 04/05/2026 Access, Treatment, LuCE News, News Web Team 04/05/2026

What is subcutaneous pembrolizumab and what does the NHS rollout mean for people living with lung cancer in Europe?

Read More
A lung cancer mutation that has resisted treatment for decades may finally have a drug
News, Treatment, Access, Diagnosis Web Team 20/04/2026 News, Treatment, Access, Diagnosis Web Team 20/04/2026

A lung cancer mutation that has resisted treatment for decades may finally have a drug

Read More
Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece
News, LuCE News, Access, Diagnosis, Treatment Web Team 18/04/2026 News, LuCE News, Access, Diagnosis, Treatment Web Team 18/04/2026

Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece

Read More
Why does lung cancer so often spread to the brain?
News, Treatment, Prevention & risk Web Team 10/04/2026 News, Treatment, Prevention & risk Web Team 10/04/2026

Why does lung cancer so often spread to the brain?

Read More
Why biomarker testing should be routine in all NSCLC
Treatment, Diagnosis, LuCE News, News Web Team 02/04/2026 Treatment, Diagnosis, LuCE News, News Web Team 02/04/2026

Why biomarker testing should be routine in all NSCLC

Read More
EMA recommends tarlatamab for relapsed extensive-stage SCLC
Treatment, LuCE News, News, Small Cell Lung Cancer Web Team 31/03/2026 Treatment, LuCE News, News, Small Cell Lung Cancer Web Team 31/03/2026

EMA recommends tarlatamab for relapsed extensive-stage SCLC

Read More
Heart health and lung cancer treatment: what new research is showing
News, LuCE News, Treatment Web Team 20/03/2026 News, LuCE News, Treatment Web Team 20/03/2026

Heart health and lung cancer treatment: what new research is showing

Read More
Cyclophosphamide supply shortage reported in Europe
News, Treatment, Access, Member Organisations Web Team 10/03/2026 News, Treatment, Access, Member Organisations Web Team 10/03/2026

Cyclophosphamide supply shortage reported in Europe

Read More
Lung cancer, immunotherapy and the gut microbiome
News, Treatment Web Team 26/02/2026 News, Treatment Web Team 26/02/2026

Lung cancer, immunotherapy and the gut microbiome

Read More

Stay in the loop

You can subscribe to updates from Lung Cancer Europe News by signing up to our monthly newsletter below. Our newsletter goes out on 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY

© Lung Cancer Europe 2026 | Designed by Laura Jones